190 related articles for article (PubMed ID: 27653836)
1. Mislocalisation of BEST1 in iPSC-derived retinal pigment epithelial cells from a family with autosomal dominant vitreoretinochoroidopathy (ADVIRC).
Carter DA; Smart MJ; Letton WV; Ramsden CM; Nommiste B; Chen LL; Fynes K; Muthiah MN; Goh P; Lane A; Powner MB; Webster AR; da Cruz L; Moore AT; Coffey PJ; Carr AF
Sci Rep; 2016 Sep; 6():33792. PubMed ID: 27653836
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Macular Changes in the First Proband of Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC) Due to a Newly Identified Mutation in BEST1.
Chen CJ; Kaufman S; Packo K; Stöhr H; Weber BH; Goldberg MF
Ophthalmic Genet; 2016; 37(1):102-8. PubMed ID: 26849243
[TBL] [Abstract][Full Text] [Related]
3. Ocular Histopathology and Immunohistochemical Analysis in the Oldest Known Individual with Autosomal Dominant Vitreoretinochoroidopathy.
Goldberg MF; McLeod S; Tso M; Packo K; Edwards M; Bhutto IA; Baldeosingh R; Eberhart C; Weber BHF; Lutty GA
Ophthalmol Retina; 2018 Apr; 2(4):360-378. PubMed ID: 29774302
[TBL] [Abstract][Full Text] [Related]
4. A novel missense mutation in BEST1 associated with an autosomal-dominant vitreoretinochoroidopathy (ADVIRC) phenotype.
Mano F; LoBue SA; Olsen TW; Marmorstein AD; Pulido JS
Ophthalmic Genet; 2018 Dec; 39(6):749-753. PubMed ID: 30222024
[TBL] [Abstract][Full Text] [Related]
5. Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies.
Nachtigal AL; Milenkovic A; Brandl C; Schulz HL; Duerr LMJ; Lang GE; Reiff C; Herrmann P; Kellner U; Weber BHF
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111077
[TBL] [Abstract][Full Text] [Related]
6. ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing.
Burgess R; MacLaren RE; Davidson AE; Urquhart JE; Holder GE; Robson AG; Moore AT; Keefe RO; Black GC; Manson FD
J Med Genet; 2009 Sep; 46(9):620-5. PubMed ID: 18611979
[TBL] [Abstract][Full Text] [Related]
7. Variable expressivity of
da Palma MM; Vargas ME; Burr A; Chen R; Pennesi ME; Weleber RG; Yang P
BMJ Open Ophthalmol; 2021; 6(1):e000813. PubMed ID: 34746433
[TBL] [Abstract][Full Text] [Related]
8. Autosomal Dominant Vitreoretinochoroidopathy With a Novel BEST1 Mutation and a Review of Reported Mutations.
Komro J; Skender S; Ross BX; Lin X
Cureus; 2022 Dec; 14(12):e32990. PubMed ID: 36712704
[TBL] [Abstract][Full Text] [Related]
9. Mutant Best1 Expression and Impaired Phagocytosis in an iPSC Model of Autosomal Recessive Bestrophinopathy.
Marmorstein AD; Johnson AA; Bachman LA; Andrews-Pfannkoch C; Knudsen T; Gilles BJ; Hill M; Gandhi JK; Marmorstein LY; Pulido JS
Sci Rep; 2018 Mar; 8(1):4487. PubMed ID: 29540715
[TBL] [Abstract][Full Text] [Related]
10. Fundus Autofluorescence and SD-OCT Document Rapid Progression in Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC) Associated with a c.256G > A Mutation in BEST1.
Kellner S; Stöhr H; Fiebig B; Weinitz S; Farmand G; Kellner U; Weber BH
Ophthalmic Genet; 2016 Jun; 37(2):201-8. PubMed ID: 26771239
[TBL] [Abstract][Full Text] [Related]
11. Evaluating BEST1 mutations in pluripotent stem cell-derived retinal pigment epithelial cells.
Kittredge A; Zhang Y; Yang T
Methods Enzymol; 2021; 654():365-382. PubMed ID: 34120722
[TBL] [Abstract][Full Text] [Related]
12. Human iPSC Modeling Reveals Mutation-Specific Responses to Gene Therapy in a Genotypically Diverse Dominant Maculopathy.
Sinha D; Steyer B; Shahi PK; Mueller KP; Valiauga R; Edwards KL; Bacig C; Steltzer SS; Srinivasan S; Abdeen A; Cory E; Periyasamy V; Siahpirani AF; Stone EM; Tucker BA; Roy S; Pattnaik BR; Saha K; Gamm DM
Am J Hum Genet; 2020 Aug; 107(2):278-292. PubMed ID: 32707085
[TBL] [Abstract][Full Text] [Related]
13. BESTROPHIN1 mutations cause defective chloride conductance in patient stem cell-derived RPE.
Moshfegh Y; Velez G; Li Y; Bassuk AG; Mahajan VB; Tsang SH
Hum Mol Genet; 2016 Jul; 25(13):2672-2680. PubMed ID: 27193166
[TBL] [Abstract][Full Text] [Related]
14. Autosomal Recessive Bestrophinopathy Is Not Associated With the Loss of Bestrophin-1 Anion Channel Function in a Patient With a Novel BEST1 Mutation.
Johnson AA; Bachman LA; Gilles BJ; Cross SD; Stelzig KE; Resch ZT; Marmorstein LY; Pulido JS; Marmorstein AD
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4619-30. PubMed ID: 26200502
[TBL] [Abstract][Full Text] [Related]
15. BEST1-related autosomal dominant vitreoretinochoroidopathy: a degenerative disease with a range of developmental ocular anomalies.
Vincent A; McAlister C; Vandenhoven C; Héon E
Eye (Lond); 2011 Jan; 25(1):113-8. PubMed ID: 21072067
[TBL] [Abstract][Full Text] [Related]
16. Induced Pluripotent Stem Cell Modeling of Best Disease and Autosomal Recessive Bestrophinopathy.
Lee JH; Oh JO; Lee CS
Yonsei Med J; 2020 Sep; 61(9):816-825. PubMed ID: 32882766
[TBL] [Abstract][Full Text] [Related]
17. Patient-specific mutations impair BESTROPHIN1's essential role in mediating Ca
Li Y; Zhang Y; Xu Y; Kittredge A; Ward N; Chen S; Tsang SH; Yang T
Elife; 2017 Oct; 6():. PubMed ID: 29063836
[TBL] [Abstract][Full Text] [Related]
18. Distinct expression requirements and rescue strategies for
Zhao Q; Kong Y; Kittredge A; Li Y; Shen Y; Zhang Y; Tsang SH; Yang T
Elife; 2021 Jun; 10():. PubMed ID: 34061021
[TBL] [Abstract][Full Text] [Related]
19. Progressive Cone Dysfunction and Geographic Atrophy of the Macula in Late Stage Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC).
Chen CJ; Goldberg MF
Ophthalmic Genet; 2016; 37(1):81-5. PubMed ID: 24564716
[TBL] [Abstract][Full Text] [Related]
20. Bestrophinopathies: perspectives on clinical disease, Bestrophin-1 function and developing therapies.
Singh Grewal S; Smith JJ; Carr AF
Ther Adv Ophthalmol; 2021; 13():2515841421997191. PubMed ID: 33738427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
